Health
AMGEN TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
AMGEN TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif. , Jan. 4, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2023 J.P. Morgan Healthcare Conference at 6:45 more...
Health
Gilead’s (GILD) Application for Trodelvy Gets EMA Validation
Gilead Sciences, Inc . GILD announced that the European Medicines Agency (EMA) has validated a Type II variation Marketing Authorization Application (MAA) for Trodelvy (sacituzumab govitecan-hziy). The MAA is seeking approval of the drug for more...
Health
Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope
NORTHAMPTON, MA / ACCESSWIRE / January 4, 2023 / Gilead Sciences On any given day on the west side of Chicago, you might encounter something unexpected. Outside a retail store or hair salon, there may more...
Health
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company’s quarterly financial report. Wall Street clearly dives into all of the other metrics and management’s input, but the EPS figure helps cut through all more...
Health
Molina’s (MOH) California Medicaid Revenues to Double in 2024
Molina Healthcare, Inc. MOH recently announced that its California Medicaid revenues are expected to double, following the confirmation received from the California Department of Health Care Services. Thanks to the finalized Medi-Cal contracts, California’s Medicaid more...
Health
Collegium Provides 2023 Financial Guidance
– Product Revenues, Net Expected in the Range of $565.0 Million to $580.0 Million – – Adjusted Operating Expenses* Expected in the Range of $135.0 Million to $145.0 Million – – Adjusted EBITDA* Expected in more...
Health
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Alcyone Therapeutics (Alcyone) have entered more...
Health
5 Toxic Stocks That Can Set Off Alarm Bells for Your Portfolio
Successful investing calls for the appropriate identification of overpriced stocks and correctly priced stocks. However, in practice, overhyped toxic stocks and fairly priced stocks are intermixed in the marketplace in such a way that it more...
Health
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
FDA Approval Currently Expected by Mid-2023 Sales of CYTOGAM® Highest Among Four IgG Products Acquired in November 2021, with Gross Margins Over 50% Ability to Manufacture CYTOGAM at Kamada’s Facility to Positively Impact Plant Utilization more...
Health
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, more...